Arrowhead Pharmaceuticals, Inc. (ARWR) vs Hinge Health, Inc. (HNGE)

A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Hinge Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Arrowhead Pharmaceuticals, Inc. logo
ARWR
Arrowhead Pharmaceuticals, Inc.
$8.79B
$62.44HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Hinge Health, Inc. logo
HNGE
Hinge Health, Inc.
$7.54B
$97.47HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT

Total return — ARWR vs HNGE

growth of $100 · dividends reinvested · last 1y
ARWR +282.8% (+282.8%/yr)HNGE +161.8% (+161.8%/yr)ARWR compounded faster over this window
100200300400500Start $1002026$383$262
ARWR HNGE

ARWR vs HNGE: by the numbers

  • •ARWR is the larger company ($8.79B vs $7.54B market cap).
  • •HNGE is profitable (15.15% net margin) while ARWR runs a net loss (-47.79%).

Metrics side by side

Valuation

MetricARWRHNGE
P/E ratioN/A75.76
Forward P/EN/A42.03
P/S ratio13.1410.47
P/B ratio18.8921.90
EV / EBITDAN/A74.33
FCF yieldN/A3.81%

Profitability

MetricARWRHNGE
Gross margin100.00%84.52%
Operating margin11.86%-92.94%
Net margin-47.79%15.15%
ROE-68.73%31.68%
ROIC-12.12%26.62%

Growth (annualized)

MetricARWRHNGE
Revenue CAGR (5Y)44.14%N/A
Total return CAGR (5Y)0.75%N/A

Frequently asked

Is ARWR or HNGE more profitable?
HNGE runs the higher net margin — ARWR at -47.79% versus HNGE at 15.15%.

Go deeper

Full ARWR analysisFull HNGE analysisInteractive comparison tool

Dig into the metrics

Hinge Health P/E ratioArrowhead Pharmaceuticals ROEHinge Health ROEArrowhead Pharmaceuticals operating marginHinge Health operating marginArrowhead Pharmaceuticals revenue growthHinge Health revenue growthArrowhead Pharmaceuticals free cash flowHinge Health free cash flow

Arrowhead Pharmaceuticals & Hinge Health appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.